| Number | GOID | Name | p-value | FDR(GOSSIP) |
FWER(GOSSIP) | Holm | Sidak | BH | BY | Bonferoni |
| 1 | 8122 | amine oxidase (copper-containing) activity | 2.5e-05 | 0.032 | 0.008 | 0.012 | 0.012 | 0.012 | 0.084 | 0.012 |
| 2 | 5634 | nucleus | 0.00018 | 0.055 | 0.047 | 0.088 | 0.084 | 0.028 | 0.19 | 0.088 |
| 3 | 7049 | cell cycle | 0.0002 | 0.055 | 0.05 | 0.1 | 0.096 | 0.028 | 0.19 | 0.1 |
| 4 | 6352 | transcription initiation | 0.00022 | 0.055 | 0.053 | 0.11 | 0.11 | 0.028 | 0.19 | 0.11 |
| 5 | 278 | mitotic cell cycle | 0.0004 | 0.057 | 0.099 | 0.2 | 0.18 | 0.029 | 0.2 | 0.2 |
| 6 | 6913 | nucleocytoplasmic transport | 0.00047 | 0.057 | 0.11 | 0.24 | 0.21 | 0.029 | 0.2 | 0.24 |
| 7 | 9987 | cellular process | 0.00063 | 0.057 | 0.14 | 0.31 | 0.27 | 0.029 | 0.2 | 0.32 |
| 8 | 50657 | nucleic acid transport | 0.00069 | 0.057 | 0.16 | 0.34 | 0.29 | 0.029 | 0.2 | 0.35 |
| 9 | 6405 | RNA-nucleus export | 0.00069 | 0.057 | 0.16 | 0.34 | 0.29 | 0.029 | 0.2 | 0.35 |
| 10 | 50658 | RNA transport | 0.00069 | 0.057 | 0.16 | 0.34 | 0.29 | 0.029 | 0.2 | 0.35 |
| 11 | 6403 | RNA localization | 0.00069 | 0.057 | 0.16 | 0.34 | 0.29 | 0.029 | 0.2 | 0.35 |
| 12 | 6366 | transcription from Pol II promoter | 0.00082 | 0.057 | 0.17 | 0.4 | 0.33 | 0.029 | 0.2 | 0.41 |
| 13 | 8151 | cell growth and/or maintenance | 0.00084 | 0.057 | 0.17 | 0.41 | 0.34 | 0.029 | 0.2 | 0.42 |
| 14 | 7292 | female gamete generation | 0.00086 | 0.057 | 0.19 | 0.42 | 0.34 | 0.029 | 0.2 | 0.43 |
| 15 | 8131 | amine oxidase activity | 0.00086 | 0.057 | 0.19 | 0.42 | 0.34 | 0.029 | 0.2 | 0.43 |
| 16 | 7059 | chromosome segregation | 0.001 | 0.057 | 0.2 | 0.5 | 0.39 | 0.032 | 0.22 | 0.52 |
| 17 | 6809 | nitric oxide biosynthesis | 0.0013 | 0.065 | 0.26 | 0.64 | 0.47 | 0.037 | 0.25 | 0.66 |
| 18 | 46209 | nitric oxide metabolism | 0.0013 | 0.065 | 0.26 | 0.64 | 0.47 | 0.037 | 0.25 | 0.66 |
| 19 | 67 | DNA replication and chromosome cycle | 0.0014 | 0.065 | 0.27 | 0.68 | 0.5 | 0.037 | 0.25 | 0.71 |
| 20 | 15931 | nucleobase, nucleoside, nucleotide and nucleic acid transport | 0.0015 | 0.065 | 0.28 | 0.75 | 0.53 | 0.039 | 0.26 | 0.78 |
| 21 | 6139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 0.0016 | 0.068 | 0.3 | 0.78 | 0.54 | 0.039 | 0.26 | 0.82 |
| 22 | 16407 | acetyltransferase activity | 0.0022 | 0.083 | 0.37 | 1 | 0.65 | 0.05 | 0.34 | 1 |
| 23 | 79 | regulation of CDK activity | 0.003 | 0.1 | 0.44 | 1 | 0.77 | 0.066 | 0.45 | 1 |
| 24 | 6351 | transcription, DNA-dependent | 0.0032 | 0.1 | 0.46 | 1 | 0.78 | 0.067 | 0.46 | 1 |
| 25 | 30528 | transcription regulator activity | 0.0034 | 0.1 | 0.47 | 1 | 0.8 | 0.067 | 0.46 | 1 |
| 26 | 7242 | intracellular signaling cascade | 0.0036 | 0.1 | 0.5 | 1 | 0.82 | 0.069 | 0.47 | 1 |
| 27 | 16641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 0.004 | 0.1 | 0.53 | 1 | 0.85 | 0.069 | 0.47 | 1 |
| 28 | 16709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD or NADH as one donor, and incorporation of one atom of oxygen | 0.004 | 0.1 | 0.53 | 1 | 0.85 | 0.069 | 0.47 | 1 |
| 29 | 86 | G2/M transition of mitotic cell cycle | 0.0042 | 0.1 | 0.54 | 1 | 0.86 | 0.069 | 0.47 | 1 |
| 30 | 7276 | gametogenesis | 0.0044 | 0.1 | 0.55 | 1 | 0.87 | 0.069 | 0.47 | 1 |
| 31 | 4693 | cyclin-dependent protein kinase activity | 0.0044 | 0.1 | 0.56 | 1 | 0.87 | 0.069 | 0.47 | 1 |
| 32 | 4402 | histone acetyltransferase activity | 0.0044 | 0.1 | 0.56 | 1 | 0.87 | 0.069 | 0.47 | 1 |
| 33 | 3929 | RAN small monomeric GTPase activity | 0.005 | 0.22 | 0.88 | 1 | 0.9 | 0.071 | 0.49 | 1 |
| 34 | 4420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity | 0.005 | 0.22 | 0.88 | 1 | 0.9 | 0.071 | 0.49 | 1 |
| 35 | 6259 | DNA metabolism | 0.005 | 0.22 | 0.88 | 1 | 0.9 | 0.071 | 0.49 | 1 |
| 36 | 6350 | transcription | 0.0052 | 0.22 | 0.89 | 1 | 0.91 | 0.072 | 0.49 | 1 |
| 37 | 8150 | biological_process | 0.0055 | 0.22 | 0.89 | 1 | 0.93 | 0.075 | 0.51 | 1 |
| 38 | 123 | histone acetyltransferase complex | 0.0058 | 0.22 | 0.9 | 1 | 0.93 | 0.077 | 0.52 | 1 |
| 39 | 8283 | cell proliferation | 0.0062 | 0.22 | 0.9 | 1 | 0.94 | 0.079 | 0.54 | 1 |
| 40 | 16638 | oxidoreductase activity, acting on the CH-NH2 group of donors | 0.0063 | 0.22 | 0.91 | 1 | 0.95 | 0.079 | 0.54 | 1 |
| 41 | 3 | reproduction | 0.0067 | 0.22 | 0.91 | 1 | 0.95 | 0.08 | 0.54 | 1 |
| 42 | 19953 | sexual reproduction | 0.0067 | 0.22 | 0.91 | 1 | 0.95 | 0.08 | 0.54 | 1 |
| 43 | 4003 | ATP dependent DNA helicase activity | 0.0074 | 0.22 | 0.92 | 1 | 0.97 | 0.086 | 0.58 | 1 |
| 44 | 7264 | small GTPase mediated signal transduction | 0.0078 | 0.22 | 0.92 | 1 | 0.97 | 0.088 | 0.6 | 1 |
| 45 | 5575 | cellular_component | 0.0079 | 0.22 | 0.92 | 1 | 0.97 | 0.088 | 0.6 | 1 |
| 46 | 4004 | ATP dependent RNA helicase activity | 0.0091 | 0.22 | 0.94 | 1 | 0.98 | 0.091 | 0.62 | 1 |
| 47 | 5507 | copper ion binding | 0.0091 | 0.22 | 0.94 | 1 | 0.98 | 0.091 | 0.62 | 1 |
| 48 | 5622 | intracellular | 0.0096 | 0.22 | 0.94 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 49 | 50790 | regulation of enzyme activity | 0.0096 | 0.22 | 0.94 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 50 | 82 | G1/S transition of mitotic cell cycle | 0.0096 | 0.22 | 0.94 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 51 | 8186 | RNA dependent ATPase activity | 0.0097 | 0.22 | 0.94 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 52 | 8354 | germ-cell migration | 0.0099 | 0.33 | 0.99 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 53 | 6597 | spermine biosynthesis | 0.0099 | 0.33 | 0.99 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 54 | 4014 | adenosylmethionine decarboxylase activity | 0.0099 | 0.33 | 0.99 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 55 | 8215 | spermine metabolism | 0.0099 | 0.33 | 0.99 | 1 | 0.99 | 0.091 | 0.62 | 1 |
| 56 | 30036 | actin cytoskeleton organization and biogenesis | 0.011 | 0.33 | 0.99 | 1 | 0.99 | 0.095 | 0.64 | 1 |
| 57 | 30029 | actin filament-based process | 0.011 | 0.33 | 0.99 | 1 | 0.99 | 0.096 | 0.65 | 1 |
| 58 | 46907 | intracellular transport | 0.012 | 0.33 | 0.99 | 1 | 1 | 0.11 | 0.72 | 1 |
| 59 | 6974 | response to DNA damage stimulus | 0.014 | 0.34 | 0.99 | 1 | 1 | 0.12 | 0.81 | 1 |
| 60 | 30175 | filopodium | 0.015 | 0.4 | 1 | 1 | 1 | 0.12 | 0.81 | 1 |
| 61 | 45502 | dynein binding | 0.015 | 0.4 | 1 | 1 | 1 | 0.12 | 0.81 | 1 |
| 62 | 8571 | non-chaperonin molecular chaperone ATPase activity | 0.015 | 0.4 | 1 | 1 | 1 | 0.12 | 0.81 | 1 |
| 63 | 19211 | phosphatase activator activity | 0.015 | 0.4 | 1 | 1 | 1 | 0.12 | 0.81 | 1 |
| 64 | 9719 | response to endogenous stimulus | 0.015 | 0.4 | 1 | 1 | 1 | 0.12 | 0.82 | 1 |
| 65 | 3724 | RNA helicase activity | 0.016 | 0.4 | 1 | 1 | 1 | 0.12 | 0.83 | 1 |
| 66 | 3773 | heat shock protein activity | 0.016 | 0.4 | 1 | 1 | 1 | 0.12 | 0.83 | 1 |
| 67 | 7582 | physiological process | 0.016 | 0.4 | 1 | 1 | 1 | 0.12 | 0.84 | 1 |
| 68 | 3678 | DNA helicase activity | 0.017 | 0.4 | 1 | 1 | 1 | 0.12 | 0.85 | 1 |
| 69 | 8152 | metabolism | 0.018 | 0.4 | 1 | 1 | 1 | 0.13 | 0.88 | 1 |
| 70 | 74 | regulation of cell cycle | 0.018 | 0.4 | 1 | 1 | 1 | 0.13 | 0.89 | 1 |
| 71 | 7028 | cytoplasm organization and biogenesis | 0.019 | 0.4 | 1 | 1 | 1 | 0.13 | 0.89 | 1 |
| 72 | 6807 | nitrogen metabolism | 0.019 | 0.4 | 1 | 1 | 1 | 0.13 | 0.9 | 1 |
| 73 | 4502 | kynurenine 3-monooxygenase activity | 0.02 | 0.45 | 1 | 1 | 1 | 0.13 | 0.9 | 1 |
| 74 | 8216 | spermidine metabolism | 0.02 | 0.45 | 1 | 1 | 1 | 0.13 | 0.9 | 1 |
| 75 | 8295 | spermidine biosynthesis | 0.02 | 0.45 | 1 | 1 | 1 | 0.13 | 0.9 | 1 |
| 76 | 8565 | protein transporter activity | 0.021 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 77 | 3700 | transcription factor activity | 0.022 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 78 | 6367 | transcription initiation from Pol II promoter | 0.022 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 79 | 8094 | DNA dependent ATPase activity | 0.022 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 80 | 6355 | regulation of transcription, DNA-dependent | 0.023 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 81 | 6576 | biogenic amine metabolism | 0.023 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 82 | 15934 | large ribosomal subunit | 0.024 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 83 | 5635 | nuclear membrane | 0.024 | 0.45 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 84 | 6384 | transcription initiation from Pol III promoter | 0.025 | 0.47 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 85 | 5161 | platelet-derived growth factor receptor binding | 0.025 | 0.47 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 86 | 8095 | inositol-1,4,5-triphosphate receptor activity | 0.025 | 0.47 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 87 | 46831 | regulation of RNA-nucleus export | 0.025 | 0.47 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 88 | 8486 | diphosphoinositol-polyphosphate diphosphatase activity | 0.025 | 0.47 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 89 | 3917 | DNA topoisomerase type I activity | 0.025 | 0.47 | 1 | 1 | 1 | 0.14 | 0.95 | 1 |
| 90 | 1505 | regulation of neurotransmitter levels | 0.027 | 0.47 | 1 | 1 | 1 | 0.15 | 0.99 | 1 |
| 91 | 16043 | cell organization and biogenesis | 0.027 | 0.47 | 1 | 1 | 1 | 0.15 | 0.99 | 1 |
| 92 | 16747 | transferase activity, transferring groups other than amino-acyl groups | 0.027 | 0.47 | 1 | 1 | 1 | 0.15 | 0.99 | 1 |
| 93 | 8415 | acyltransferase activity | 0.027 | 0.47 | 1 | 1 | 1 | 0.15 | 0.99 | 1 |
| 94 | 3925 | small monomeric GTPase activity | 0.028 | 0.47 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 95 | 45449 | regulation of transcription | 0.028 | 0.47 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 96 | 6281 | DNA repair | 0.029 | 0.47 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 97 | 4406 | H3/H4 histone acetyltransferase activity | 0.03 | 0.5 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 98 | 5913 | cell-cell adherens junction | 0.03 | 0.5 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 99 | 4517 | nitric-oxide synthase activity | 0.03 | 0.5 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 100 | 5068 | transmembrane receptor protein tyrosine kinase adaptor protein activity | 0.03 | 0.5 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 101 | 7265 | RAS protein signal transduction | 0.03 | 0.5 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 102 | 6886 | intracellular protein transport | 0.03 | 0.5 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 103 | 4857 | enzyme inhibitor activity | 0.03 | 0.5 | 1 | 1 | 1 | 0.15 | 1 | 1 |
| 104 | 16746 | transferase activity, transferring acyl groups | 0.033 | 0.5 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 105 | 5694 | chromosome | 0.034 | 0.5 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 106 | 7005 | mitochondrion organization and biogenesis | 0.034 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 107 | 6265 | DNA topological change | 0.034 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 108 | 16873 | other isomerase activity | 0.034 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 109 | 3916 | DNA topoisomerase activity | 0.034 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 110 | 5869 | dynactin complex | 0.034 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 111 | 127 | transcription factor TFIIIC complex | 0.034 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 112 | 12505 | endomembrane system | 0.035 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 113 | 6996 | organelle organization and biogenesis | 0.036 | 0.52 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 114 | 6575 | amino acid derivative metabolism | 0.038 | 0.53 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 115 | 6268 | DNA unwinding | 0.039 | 0.53 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 116 | 5086 | ARF guanyl-nucleotide exchange factor activity | 0.039 | 0.53 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 117 | 6596 | polyamine biosynthesis | 0.039 | 0.53 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 118 | 5224 | ATP-binding and phosphorylation-dependent chloride channel activity | 0.039 | 0.53 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 119 | 16299 | regulator of G-protein signaling activity | 0.039 | 0.53 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 120 | 19888 | protein phosphatase regulator activity | 0.039 | 0.53 | 1 | 1 | 1 | 0.16 | 1 | 1 |
| 121 | 30529 | ribonucleoprotein complex | 0.04 | 0.53 | 1 | 1 | 1 | 0.17 | 1 | 1 |
| 122 | 15031 | protein transport | 0.041 | 0.53 | 1 | 1 | 1 | 0.17 | 1 | 1 |
| 123 | 6611 | protein-nucleus export | 0.044 | 0.57 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 124 | 5545 | phosphatidylinositol binding | 0.044 | 0.57 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 125 | 5844 | polysome | 0.044 | 0.57 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 126 | 19208 | phosphatase regulator activity | 0.044 | 0.57 | 1 | 1 | 1 | 0.18 | 1 | 1 |
| 127 | 3709 | RNA polymerase III transcription factor activity | 0.049 | 0.59 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 128 | 16202 | regulation of myogenesis | 0.049 | 0.59 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 129 | 6595 | polyamine metabolism | 0.049 | 0.59 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 130 | 19748 | secondary metabolism | 0.049 | 0.59 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 131 | 7015 | actin filament organization | 0.049 | 0.59 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 132 | 5623 | cell | 0.051 | 0.59 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 133 | 5066 | transmembrane receptor protein tyrosine kinase signaling protein activity | 0.051 | 0.59 | 1 | 1 | 1 | 0.19 | 1 | 1 |
| 134 | 7067 | mitosis | 0.052 | 0.59 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 135 | 5868 | cytoplasmic dynein complex | 0.053 | 0.6 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 136 | 3811 | complement activity | 0.053 | 0.6 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 137 | 8543 | FGF receptor signaling pathway | 0.053 | 0.6 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 138 | 87 | M phase of mitotic cell cycle | 0.055 | 0.6 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 139 | 7010 | cytoskeleton organization and biogenesis | 0.056 | 0.6 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 140 | 5643 | nuclear pore | 0.058 | 0.6 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 141 | 46930 | pore complex | 0.058 | 0.6 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 142 | 18958 | phenol metabolism | 0.058 | 0.61 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 143 | 6584 | catecholamine metabolism | 0.058 | 0.61 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 144 | 4730 | pseudouridylate synthase activity | 0.058 | 0.61 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 145 | 5912 | adherens junction | 0.058 | 0.61 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 146 | 6605 | protein targeting | 0.059 | 0.61 | 1 | 1 | 1 | 0.2 | 1 | 1 |
| 147 | 5639 | integral to nuclear inner membrane | 0.063 | 0.63 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 148 | 5217 | intracellular ligand-gated ion channel activity | 0.063 | 0.63 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 149 | 30234 | enzyme regulator activity | 0.063 | 0.63 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 150 | 6260 | DNA replication | 0.064 | 0.63 | 1 | 1 | 1 | 0.21 | 1 | 1 |
| 151 | 84 | S phase of mitotic cell cycle | 0.065 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1 |
| 152 | 5158 | insulin receptor binding | 0.068 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1 |
| 153 | 42133 | neurotransmitter metabolism | 0.068 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1 |
| 154 | 5840 | ribosome | 0.07 | 0.63 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 155 | 5489 | electron transporter activity | 0.07 | 0.63 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 156 | 7165 | signal transduction | 0.07 | 0.63 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 157 | 7154 | cell communication | 0.071 | 0.63 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 158 | 7268 | synaptic transmission | 0.072 | 0.63 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 159 | 35091 | phosphoinositide binding | 0.072 | 0.64 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 160 | 6950 | response to stress | 0.073 | 0.64 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 161 | 6606 | protein-nucleus import | 0.074 | 0.64 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 162 | 50800 | hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement | 0.075 | 0.64 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 163 | 5667 | transcription factor complex | 0.076 | 0.64 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 164 | 7185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 0.077 | 0.65 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 165 | 5669 | transcription factor TFIID complex | 0.077 | 0.65 | 1 | 1 | 1 | 0.23 | 1 | 1 |
| 166 | 9058 | biosynthesis | 0.079 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1 |
| 167 | 3735 | structural constituent of ribosome | 0.08 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1 |
| 168 | 8320 | protein carrier activity | 0.081 | 0.67 | 1 | 1 | 1 | 0.24 | 1 | 1 |
| 169 | 7267 | cell-cell signaling | 0.084 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 170 | 19226 | transmission of nerve impulse | 0.084 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 171 | 280 | nuclear division | 0.085 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 172 | 46822 | regulation of nucleocytoplasmic transport | 0.086 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 173 | 19722 | calcium-mediated signaling | 0.086 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 174 | 5637 | nuclear inner membrane | 0.086 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 175 | 7051 | spindle assembly | 0.086 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 176 | 7052 | mitotic spindle assembly | 0.086 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 177 | 3713 | transcription coactivator activity | 0.089 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 178 | 5730 | nucleolus | 0.09 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 179 | 30182 | neuron differentiation | 0.091 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 180 | 8406 | gonad development | 0.091 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 181 | 16817 | hydrolase activity, acting on acid anhydrides | 0.091 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 182 | 6928 | cell motility | 0.092 | 0.67 | 1 | 1 | 1 | 0.25 | 1 | 1 |
| 183 | 279 | M phase | 0.096 | 0.68 | 1 | 1 | 1 | 0.26 | 1 | 1 |
| 184 | 3924 | GTPase activity | 0.099 | 0.69 | 1 | 1 | 1 | 0.27 | 1 | 1 |
| 185 | 6302 | double-strand break repair | 0.1 | 0.71 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 186 | 42401 | biogenic amine biosynthesis | 0.1 | 0.71 | 1 | 1 | 1 | 0.28 | 1 | 1 |
| 187 | 45012 | MHC class II receptor activity | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 188 | 19884 | antigen presentation, exogenous antigen | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 189 | 19886 | antigen processing, exogenous antigen via MHC class II | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 190 | 781 | chromosome, telomeric region | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 191 | 50789 | regulation of biological process | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 192 | 16705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 193 | 16491 | oxidoreductase activity | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 194 | 19212 | phosphatase inhibitor activity | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 195 | 8080 | N-acetyltransferase activity | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 196 | 3712 | transcription cofactor activity | 0.11 | 0.72 | 1 | 1 | 1 | 0.29 | 1 | 1 |
| 197 | 3705 | RNA polymerase II transcription factor activity, enhancer binding | 0.12 | 0.73 | 1 | 1 | 1 | 0.3 | 1 | 1 |
| 198 | 7017 | microtubule-based process | 0.12 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 199 | 6383 | transcription from Pol III promoter | 0.12 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 200 | 42398 | amino acid derivative biosynthesis | 0.12 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 201 | 5515 | protein binding | 0.12 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 202 | 7222 | frizzled signaling pathway | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 203 | 16410 | N-acyltransferase activity | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 204 | 6364 | rRNA processing | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 205 | 4866 | endopeptidase inhibitor activity | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 206 | 30414 | protease inhibitor activity | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 207 | 6406 | mRNA-nucleus export | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 208 | 6958 | complement activation, classical pathway | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 209 | 8022 | protein C-terminus binding | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 210 | 19079 | viral genome replication | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 211 | 7131 | meiotic recombination | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 212 | 72 | M-phase specific microtubule process | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 213 | 6695 | cholesterol biosynthesis | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 214 | 6753 | nucleoside phosphate metabolism | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 215 | 6754 | ATP biosynthesis | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 216 | 7269 | neurotransmitter secretion | 0.13 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 217 | 16023 | cytoplasmic vesicle | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 218 | 6725 | aromatic compound metabolism | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 219 | 8134 | transcription factor binding | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 220 | 5525 | GTP binding | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 221 | 7128 | meiotic prophase I | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 222 | 6937 | regulation of muscle contraction | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 223 | 7127 | meiosis I | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 224 | 7519 | myogenesis | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 225 | 19001 | guanyl nucleotide binding | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 226 | 785 | chromatin | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 227 | 3723 | RNA binding | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 228 | 4869 | cysteine protease inhibitor activity | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 229 | 7004 | telomerase-dependent telomere maintenance | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 230 | 723 | telomere maintenance | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 231 | 776 | kinetochore | 0.14 | 0.73 | 1 | 1 | 1 | 0.31 | 1 | 1 |
| 232 | 16072 | rRNA metabolism | 0.15 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 233 | 3677 | DNA binding | 0.15 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 234 | 8083 | growth factor activity | 0.15 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 235 | 910 | cytokinesis | 0.15 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 236 | 30286 | dynein complex | 0.15 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 237 | 19058 | viral infectious cycle | 0.15 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 238 | 5654 | nucleoplasm | 0.15 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1 |
| 239 | 16126 | sterol biosynthesis | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 240 | 5842 | cytosolic large ribosomal subunit (sensu Eukarya) | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 241 | 8372 | cellular_component unknown | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 242 | 3702 | RNA polymerase II transcription factor activity | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 243 | 7001 | chromosome organization and biogenesis (sensu Eukarya) | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 244 | 775 | chromosome, pericentric region | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 245 | 6956 | complement activation | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 246 | 9187 | cyclic nucleotide metabolism | 0.16 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 247 | 6936 | muscle contraction | 0.16 | 0.74 | 1 | 1 | 1 | 0.33 | 1 | 1 |
| 248 | 16049 | cell growth | 0.17 | 0.74 | 1 | 1 | 1 | 0.34 | 1 | 1 |
| 249 | 46034 | ATP metabolism | 0.17 | 0.74 | 1 | 1 | 1 | 0.34 | 1 | 1 |
| 250 | 6997 | nuclear organization and biogenesis | 0.17 | 0.74 | 1 | 1 | 1 | 0.34 | 1 | 1 |
| 251 | 9145 | purine nucleoside triphosphate biosynthesis | 0.17 | 0.74 | 1 | 1 | 1 | 0.34 | 1 | 1 |
| 252 | 9206 | purine ribonucleoside triphosphate biosynthesis | 0.17 | 0.74 | 1 | 1 | 1 | 0.34 | 1 | 1 |
| 253 | 9201 | ribonucleoside triphosphate biosynthesis | 0.17 | 0.74 | 1 | 1 | 1 | 0.34 | 1 | 1 |
| 254 | 6417 | regulation of protein biosynthesis | 0.18 | 0.74 | 1 | 1 | 1 | 0.35 | 1 | 1 |
| 255 | 9142 | nucleoside triphosphate biosynthesis | 0.18 | 0.74 | 1 | 1 | 1 | 0.35 | 1 | 1 |
| 256 | 16831 | carboxy-lyase activity | 0.18 | 0.74 | 1 | 1 | 1 | 0.35 | 1 | 1 |
| 257 | 46966 | thyroid hormone receptor binding | 0.18 | 0.74 | 1 | 1 | 1 | 0.35 | 1 | 1 |
| 258 | 16032 | viral life cycle | 0.18 | 0.75 | 1 | 1 | 1 | 0.35 | 1 | 1 |
| 259 | 7046 | ribosome biogenesis | 0.19 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 260 | 7179 | transforming growth factor beta receptor signaling pathway | 0.19 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1 |
| 261 | 16481 | negative regulation of transcription | 0.19 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 262 | 9117 | nucleotide metabolism | 0.2 | 0.77 | 1 | 1 | 1 | 0.37 | 1 | 1 |
| 263 | 19882 | antigen presentation | 0.2 | 0.77 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 264 | 42254 | ribosome biogenesis and assembly | 0.2 | 0.77 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 265 | 5254 | chloride channel activity | 0.2 | 0.77 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 266 | 9199 | ribonucleoside triphosphate metabolism | 0.21 | 0.78 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 267 | 9144 | purine nucleoside triphosphate metabolism | 0.21 | 0.78 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 268 | 9205 | purine ribonucleoside triphosphate metabolism | 0.21 | 0.78 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 269 | 30333 | antigen processing | 0.21 | 0.78 | 1 | 1 | 1 | 0.38 | 1 | 1 |
| 270 | 6954 | inflammatory response | 0.21 | 0.78 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 271 | 8285 | negative regulation of cell proliferation | 0.21 | 0.78 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 272 | 8021 | synaptic vesicle | 0.21 | 0.79 | 1 | 1 | 1 | 0.39 | 1 | 1 |
| 273 | 45087 | innate immune response | 0.22 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 274 | 9141 | nucleoside triphosphate metabolism | 0.22 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 275 | 8026 | ATP dependent helicase activity | 0.22 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 276 | 3931 | Rho small monomeric GTPase activity | 0.22 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 277 | 7178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 0.22 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 278 | 5125 | cytokine activity | 0.22 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 279 | 8138 | protein tyrosine/serine/threonine phosphatase activity | 0.23 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 280 | 5215 | transporter activity | 0.23 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 281 | 16251 | general RNA polymerase II transcription factor activity | 0.23 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 282 | 3930 | RAS small monomeric GTPase activity | 0.23 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 283 | 7126 | meiosis | 0.23 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 284 | 16830 | carbon-carbon lyase activity | 0.23 | 0.79 | 1 | 1 | 1 | 0.4 | 1 | 1 |
| 285 | 5253 | anion channel activity | 0.23 | 0.79 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 286 | 5102 | receptor binding | 0.23 | 0.79 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 287 | 16829 | lyase activity | 0.24 | 0.79 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 288 | 9059 | macromolecule biosynthesis | 0.24 | 0.8 | 1 | 1 | 1 | 0.41 | 1 | 1 |
| 289 | 16477 | cell migration | 0.24 | 0.8 | 1 | 1 | 1 | 0.42 | 1 | 1 |
| 290 | 3777 | microtubule motor activity | 0.24 | 0.8 | 1 | 1 | 1 | 0.42 | 1 | 1 |
| 291 | 8544 | epidermal differentiation | 0.25 | 0.81 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 292 | 4386 | helicase activity | 0.25 | 0.81 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 293 | 5543 | phospholipid binding | 0.25 | 0.81 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 294 | 9152 | purine ribonucleotide biosynthesis | 0.25 | 0.81 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 295 | 6752 | group transfer coenzyme metabolism | 0.25 | 0.81 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 296 | 3754 | chaperone activity | 0.25 | 0.81 | 1 | 1 | 1 | 0.43 | 1 | 1 |
| 297 | 3676 | nucleic acid binding | 0.26 | 0.81 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 298 | 9308 | amine metabolism | 0.26 | 0.82 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 299 | 5768 | endosome | 0.26 | 0.82 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 300 | 15630 | microtubule cytoskeleton | 0.27 | 0.82 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 301 | 16564 | transcriptional repressor activity | 0.27 | 0.82 | 1 | 1 | 1 | 0.44 | 1 | 1 |
| 302 | 226 | microtubule cytoskeleton organization and biogenesis | 0.27 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 303 | 9889 | regulation of biosynthesis | 0.27 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 304 | 6955 | immune response | 0.27 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 305 | 9260 | ribonucleotide biosynthesis | 0.27 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 306 | 15935 | small ribosomal subunit | 0.28 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 307 | 16836 | hydro-lyase activity | 0.28 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 308 | 3682 | chromatin binding | 0.28 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 309 | 5070 | SH3/SH2 adaptor protein activity | 0.28 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 310 | 9150 | purine ribonucleotide metabolism | 0.28 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 311 | 7167 | enzyme linked receptor protein signaling pathway | 0.28 | 0.82 | 1 | 1 | 1 | 0.45 | 1 | 1 |
| 312 | 16192 | vesicle-mediated transport | 0.28 | 0.82 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 313 | 7398 | ectoderm development | 0.29 | 0.82 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 314 | 6164 | purine nucleotide biosynthesis | 0.29 | 0.82 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 315 | 15276 | ligand-gated ion channel activity | 0.29 | 0.82 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 316 | 16835 | carbon-oxygen lyase activity | 0.29 | 0.82 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 317 | 6887 | exocytosis | 0.29 | 0.82 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 318 | 5069 | transmembrane receptor protein tyrosine kinase docking protein activity | 0.29 | 0.82 | 1 | 1 | 1 | 0.46 | 1 | 1 |
| 319 | 15992 | proton transport | 0.3 | 0.82 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 320 | 6818 | hydrogen transport | 0.3 | 0.82 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 321 | 9309 | amine biosynthesis | 0.3 | 0.82 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 322 | 45111 | intermediate filament cytoskeleton | 0.3 | 0.82 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 323 | 5882 | intermediate filament | 0.3 | 0.82 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 324 | 5789 | endoplasmic reticulum membrane | 0.3 | 0.82 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 325 | 5830 | cytosolic ribosome (sensu Eukarya) | 0.3 | 0.82 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 326 | 19935 | cyclic-nucleotide-mediated signaling | 0.31 | 0.83 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 327 | 8203 | cholesterol metabolism | 0.31 | 0.83 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 328 | 42175 | nuclear envelope-endoplasmic reticulum network | 0.31 | 0.83 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 329 | 9259 | ribonucleotide metabolism | 0.31 | 0.83 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 330 | 8610 | lipid biosynthesis | 0.31 | 0.83 | 1 | 1 | 1 | 0.47 | 1 | 1 |
| 331 | 46903 | secretion | 0.32 | 0.83 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 332 | 19222 | regulation of metabolism | 0.32 | 0.83 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 333 | 6952 | defense response | 0.32 | 0.83 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 334 | 6163 | purine nucleotide metabolism | 0.32 | 0.83 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 335 | 6310 | DNA recombination | 0.32 | 0.83 | 1 | 1 | 1 | 0.48 | 1 | 1 |
| 336 | 16125 | sterol metabolism | 0.33 | 0.83 | 1 | 1 | 1 | 0.49 | 1 | 1 |
| 337 | 6066 | alcohol metabolism | 0.33 | 0.83 | 1 | 1 | 1 | 0.49 | 1 | 1 |
| 338 | 30136 | clathrin-coated vesicle | 0.33 | 0.83 | 1 | 1 | 1 | 0.49 | 1 | 1 |
| 339 | 16591 | DNA-directed RNA polymerase II, holoenzyme | 0.34 | 0.83 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 340 | 6810 | transport | 0.34 | 0.83 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 341 | 6694 | steroid biosynthesis | 0.34 | 0.83 | 1 | 1 | 1 | 0.5 | 1 | 1 |
| 342 | 4497 | monooxygenase activity | 0.35 | 0.84 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 343 | 9108 | coenzyme biosynthesis | 0.35 | 0.84 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 344 | 16818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 0.35 | 0.84 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 345 | 5777 | peroxisome | 0.35 | 0.84 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 346 | 42579 | microbody | 0.35 | 0.84 | 1 | 1 | 1 | 0.51 | 1 | 1 |
| 347 | 7050 | cell cycle arrest | 0.36 | 0.84 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 348 | 50794 | regulation of cellular process | 0.36 | 0.84 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 349 | 9611 | response to wounding | 0.36 | 0.84 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 350 | 8047 | enzyme activator activity | 0.36 | 0.84 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 351 | 122 | negative regulation of transcription from Pol II promoter | 0.36 | 0.85 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 352 | 15629 | actin cytoskeleton | 0.36 | 0.85 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 353 | 6412 | protein biosynthesis | 0.37 | 0.85 | 1 | 1 | 1 | 0.52 | 1 | 1 |
| 354 | 5057 | receptor signaling protein activity | 0.37 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1 |
| 355 | 4840 | ubiquitin conjugating enzyme activity | 0.37 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1 |
| 356 | 9888 | histogenesis | 0.37 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1 |
| 357 | 4871 | signal transducer activity | 0.38 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1 |
| 358 | 30135 | coated vesicle | 0.38 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1 |
| 359 | 8639 | small protein conjugating enzyme activity | 0.38 | 0.85 | 1 | 1 | 1 | 0.54 | 1 | 1 |
| 360 | 46914 | transition metal ion binding | 0.39 | 0.86 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 361 | 9607 | response to biotic stimulus | 0.4 | 0.86 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 362 | 19932 | second-messenger-mediated signaling | 0.4 | 0.86 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 363 | 3928 | RAB small monomeric GTPase activity | 0.4 | 0.86 | 1 | 1 | 1 | 0.55 | 1 | 1 |
| 364 | 6261 | DNA dependent DNA replication | 0.4 | 0.86 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 365 | 5488 | binding | 0.41 | 0.86 | 1 | 1 | 1 | 0.56 | 1 | 1 |
| 366 | 46138 | coenzyme and prosthetic group biosynthesis | 0.41 | 0.86 | 1 | 1 | 1 | 0.57 | 1 | 1 |
| 367 | 5624 | membrane fraction | 0.42 | 0.86 | 1 | 1 | 1 | 0.57 | 1 | 1 |
| 368 | 16616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 0.42 | 0.86 | 1 | 1 | 1 | 0.57 | 1 | 1 |
| 369 | 48232 | male gamete generation | 0.43 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 370 | 5875 | microtubule associated complex | 0.43 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 371 | 7283 | spermatogenesis | 0.43 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 372 | 1558 | regulation of cell growth | 0.43 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 373 | 3674 | molecular_function | 0.43 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 374 | 6333 | chromatin assembly/disassembly | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 375 | 6916 | anti-apoptosis | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 376 | 43066 | negative regulation of apoptosis | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 377 | 5911 | intercellular junction | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 378 | 16055 | Wnt receptor signaling pathway | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 379 | 16614 | oxidoreductase activity, acting on CH-OH group of donors | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 380 | 5198 | structural molecule activity | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 381 | 9165 | nucleotide biosynthesis | 0.44 | 0.86 | 1 | 1 | 1 | 0.58 | 1 | 1 |
| 382 | 45892 | negative regulation of transcription, DNA-dependent | 0.45 | 0.86 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 383 | 5194 | cell adhesion molecule activity | 0.45 | 0.86 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 384 | 6915 | apoptosis | 0.45 | 0.86 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 385 | 12501 | programmed cell death | 0.45 | 0.86 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 386 | 6519 | amino acid and derivative metabolism | 0.45 | 0.86 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 387 | 5085 | guanyl-nucleotide exchange factor activity | 0.45 | 0.87 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 388 | 16568 | chromatin modification | 0.45 | 0.87 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 389 | 16327 | apicolateral plasma membrane | 0.46 | 0.87 | 1 | 1 | 1 | 0.59 | 1 | 1 |
| 390 | 30054 | cell junction | 0.46 | 0.87 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 391 | 5737 | cytoplasm | 0.47 | 0.87 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 392 | 5783 | endoplasmic reticulum | 0.47 | 0.87 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 393 | 5200 | structural constituent of cytoskeleton | 0.47 | 0.87 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 394 | 42127 | regulation of cell proliferation | 0.47 | 0.87 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 395 | 6732 | coenzyme metabolism | 0.47 | 0.87 | 1 | 1 | 1 | 0.6 | 1 | 1 |
| 396 | 16064 | humoral defense mechanism (sensu Vertebrata) | 0.48 | 0.88 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 397 | 5554 | molecular_function unknown | 0.48 | 0.88 | 1 | 1 | 1 | 0.61 | 1 | 1 |
| 398 | 3714 | transcription corepressor activity | 0.49 | 0.89 | 1 | 1 | 1 | 0.62 | 1 | 1 |
| 399 | 8219 | cell death | 0.49 | 0.89 | 1 | 1 | 1 | 0.62 | 1 | 1 |
| 400 | 6357 | regulation of transcription from Pol II promoter | 0.5 | 0.89 | 1 | 1 | 1 | 0.62 | 1 | 1 |
| 401 | 16265 | death | 0.5 | 0.89 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 402 | 8369 | obsolete molecular function | 0.5 | 0.89 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 403 | 16853 | isomerase activity | 0.5 | 0.89 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 404 | 7169 | transmembrane receptor protein tyrosine kinase signaling pathway | 0.51 | 0.89 | 1 | 1 | 1 | 0.63 | 1 | 1 |
| 405 | 4842 | ubiquitin-protein ligase activity | 0.52 | 0.91 | 1 | 1 | 1 | 0.65 | 1 | 1 |
| 406 | 42623 | ATPase activity, coupled | 0.53 | 0.91 | 1 | 1 | 1 | 0.65 | 1 | 1 |
| 407 | 17076 | purine nucleotide binding | 0.53 | 0.91 | 1 | 1 | 1 | 0.66 | 1 | 1 |
| 408 | 6731 | coenzyme and prosthetic group metabolism | 0.54 | 0.91 | 1 | 1 | 1 | 0.66 | 1 | 1 |
| 409 | 7517 | muscle development | 0.54 | 0.91 | 1 | 1 | 1 | 0.66 | 1 | 1 |
| 410 | 4672 | protein kinase activity | 0.54 | 0.91 | 1 | 1 | 1 | 0.66 | 1 | 1 |
| 411 | 6468 | protein amino acid phosphorylation | 0.54 | 0.91 | 1 | 1 | 1 | 0.66 | 1 | 1 |
| 412 | 3774 | motor activity | 0.55 | 0.91 | 1 | 1 | 1 | 0.66 | 1 | 1 |
| 413 | 166 | nucleotide binding | 0.55 | 0.91 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 414 | 7601 | vision | 0.55 | 0.91 | 1 | 1 | 1 | 0.67 | 1 | 1 |
| 415 | 6959 | humoral immune response | 0.56 | 0.91 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 416 | 16887 | ATPase activity | 0.56 | 0.91 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 417 | 4 | biological_process unknown | 0.56 | 0.91 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 418 | 9583 | perception of light | 0.57 | 0.91 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 419 | 6118 | electron transport | 0.57 | 0.91 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 420 | 6457 | protein folding | 0.57 | 0.91 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 421 | 8202 | steroid metabolism | 0.57 | 0.91 | 1 | 1 | 1 | 0.68 | 1 | 1 |
| 422 | 4674 | protein serine/threonine kinase activity | 0.58 | 0.91 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 423 | 5516 | calmodulin binding | 0.58 | 0.91 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 424 | 9416 | response to light | 0.58 | 0.91 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 425 | 6796 | phosphate metabolism | 0.58 | 0.91 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 426 | 6793 | phosphorus metabolism | 0.58 | 0.91 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 427 | 6511 | ubiquitin-dependent protein catabolism | 0.59 | 0.91 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 428 | 19941 | modification-dependent protein catabolism | 0.59 | 0.91 | 1 | 1 | 1 | 0.69 | 1 | 1 |
| 429 | 6512 | ubiquitin cycle | 0.6 | 0.91 | 1 | 1 | 1 | 0.7 | 1 | 1 |
| 430 | 16310 | phosphorylation | 0.6 | 0.91 | 1 | 1 | 1 | 0.7 | 1 | 1 |
| 431 | 16881 | acid-D-amino acid ligase activity | 0.6 | 0.91 | 1 | 1 | 1 | 0.7 | 1 | 1 |
| 432 | 4721 | phosphoprotein phosphatase activity | 0.61 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 433 | 6470 | protein amino acid dephosphorylation | 0.61 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 434 | 16311 | dephosphorylation | 0.61 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 435 | 8289 | lipid binding | 0.61 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 436 | 9613 | response to pest/pathogen/parasite | 0.61 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 437 | 9653 | morphogenesis | 0.62 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 438 | 16301 | kinase activity | 0.62 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 439 | 15891 | siderochrome transport | 0.62 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 440 | 5794 | Golgi apparatus | 0.62 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 441 | 45045 | secretory pathway | 0.63 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 442 | 19538 | protein metabolism | 0.63 | 0.91 | 1 | 1 | 1 | 0.71 | 1 | 1 |
| 443 | 9314 | response to radiation | 0.63 | 0.91 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 444 | 3824 | catalytic activity | 0.63 | 0.91 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 445 | 8380 | RNA splicing | 0.64 | 0.91 | 1 | 1 | 1 | 0.72 | 1 | 1 |
| 446 | 30154 | cell differentiation | 0.65 | 0.92 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 447 | 16773 | phosphotransferase activity, alcohol group as acceptor | 0.65 | 0.92 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 448 | 9605 | response to external stimulus | 0.66 | 0.92 | 1 | 1 | 1 | 0.73 | 1 | 1 |
| 449 | 267 | cell fraction | 0.66 | 0.92 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 450 | 5739 | mitochondrion | 0.66 | 0.92 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 451 | 5083 | small GTPase regulatory/interacting protein activity | 0.67 | 0.92 | 1 | 1 | 1 | 0.74 | 1 | 1 |
| 452 | 6325 | establishment and/or maintenance of chromatin architecture | 0.67 | 0.92 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 453 | 6396 | RNA processing | 0.68 | 0.92 | 1 | 1 | 1 | 0.75 | 1 | 1 |
| 454 | 6323 | DNA packaging | 0.69 | 0.93 | 1 | 1 | 1 | 0.76 | 1 | 1 |
| 455 | 16879 | ligase activity, forming carbon-nitrogen bonds | 0.69 | 0.93 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 456 | 9887 | organogenesis | 0.7 | 0.93 | 1 | 1 | 1 | 0.77 | 1 | 1 |
| 457 | 16070 | RNA metabolism | 0.71 | 0.93 | 1 | 1 | 1 | 0.78 | 1 | 1 |
| 458 | 8270 | zinc ion binding | 0.72 | 0.94 | 1 | 1 | 1 | 0.79 | 1 | 1 |
| 459 | 16791 | phosphoric monoester hydrolase activity | 0.72 | 0.94 | 1 | 1 | 1 | 0.79 | 1 | 1 |
| 460 | 5856 | cytoskeleton | 0.73 | 0.94 | 1 | 1 | 1 | 0.79 | 1 | 1 |
| 461 | 5886 | plasma membrane | 0.73 | 0.94 | 1 | 1 | 1 | 0.79 | 1 | 1 |
| 462 | 6464 | protein modification | 0.73 | 0.94 | 1 | 1 | 1 | 0.79 | 1 | 1 |
| 463 | 15672 | monovalent inorganic cation transport | 0.73 | 0.94 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 464 | 42981 | regulation of apoptosis | 0.74 | 0.94 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 465 | 7166 | cell surface receptor linked signal transduction | 0.74 | 0.94 | 1 | 1 | 1 | 0.8 | 1 | 1 |
| 466 | 9582 | perception of abiotic stimulus | 0.75 | 0.94 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 467 | 4872 | receptor activity | 0.75 | 0.94 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 468 | 7600 | sensory perception | 0.75 | 0.94 | 1 | 1 | 1 | 0.81 | 1 | 1 |
| 469 | 16740 | transferase activity | 0.78 | 0.95 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 470 | 9581 | perception of external stimulus | 0.78 | 0.95 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 471 | 5216 | ion channel activity | 0.79 | 0.95 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 472 | 7275 | development | 0.79 | 0.95 | 1 | 1 | 1 | 0.84 | 1 | 1 |
| 473 | 16772 | transferase activity, transferring phosphorus-containing groups | 0.8 | 0.95 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 474 | 5615 | extracellular space | 0.81 | 0.95 | 1 | 1 | 1 | 0.85 | 1 | 1 |
| 475 | 5524 | ATP binding | 0.81 | 0.95 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 476 | 15268 | alpha-type channel activity | 0.81 | 0.95 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 477 | 30695 | GTPase regulator activity | 0.81 | 0.95 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 478 | 42578 | phosphoric ester hydrolase activity | 0.82 | 0.95 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 479 | 30554 | adenyl nucleotide binding | 0.82 | 0.95 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 480 | 15267 | channel/pore class transporter activity | 0.82 | 0.95 | 1 | 1 | 1 | 0.86 | 1 | 1 |
| 481 | 5829 | cytosol | 0.83 | 0.95 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 482 | 6629 | lipid metabolism | 0.83 | 0.95 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 483 | 16874 | ligase activity | 0.83 | 0.95 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 484 | 5576 | extracellular | 0.84 | 0.95 | 1 | 1 | 1 | 0.87 | 1 | 1 |
| 485 | 7155 | cell adhesion | 0.87 | 0.96 | 1 | 1 | 1 | 0.9 | 1 | 1 |
| 486 | 4888 | transmembrane receptor activity | 0.88 | 0.96 | 1 | 1 | 1 | 0.91 | 1 | 1 |
| 487 | 16787 | hydrolase activity | 0.89 | 0.97 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 488 | 6812 | cation transport | 0.9 | 0.97 | 1 | 1 | 1 | 0.92 | 1 | 1 |
| 489 | 7186 | G-protein coupled receptor protein signaling pathway | 0.9 | 0.97 | 1 | 1 | 1 | 0.93 | 1 | 1 |
| 490 | 16021 | integral to membrane | 0.91 | 0.97 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 491 | 5386 | carrier activity | 0.92 | 0.97 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 492 | 16020 | membrane | 0.92 | 0.97 | 1 | 1 | 1 | 0.94 | 1 | 1 |
| 493 | 9628 | response to abiotic stimulus | 0.94 | 0.97 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 494 | 46872 | metal ion binding | 0.94 | 0.97 | 1 | 1 | 1 | 0.95 | 1 | 1 |
| 495 | 6811 | ion transport | 0.96 | 0.97 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 496 | 16788 | hydrolase activity, acting on ester bonds | 0.96 | 0.97 | 1 | 1 | 1 | 0.97 | 1 | 1 |
| 497 | 6508 | proteolysis and peptidolysis | 0.97 | 0.97 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 498 | 30163 | protein catabolism | 0.97 | 0.97 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 499 | 9057 | macromolecule catabolism | 0.97 | 0.97 | 1 | 1 | 1 | 0.98 | 1 | 1 |
| 500 | 5887 | integral to plasma membrane | 0.98 | 0.98 | 1 | 1 | 1 | 0.99 | 1 | 1 |
| 501 | 9056 | catabolism | 0.99 | 0.98 | 1 | 1 | 1 | 1 | 1 | 1 |
| 502 | 3673 | Gene_Ontology | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| | Number of significant terms | 131 | 1 | 2 | 1 | 1 | 21 | 0 | 1 |